NASDAQ
Bicara Therapeutics Inc. Common Stock (BCAX) has a free cash flow growth of -55.73% as of Friday, May 29, 2026. This represents a 1293.86% decrease compared to its 12-month average of 4.67%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.